Thomasville National Bank Medi Wound Ltd. Transaction History

Thomasville National Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 03, 2022	BUY	$1.35 - $9.8 $6,750 - $49,000	5,000 Added 19.23%	31,000 $43,000
Q3 2021 Oct 04, 2021	SELL	$3.34 - $4.63 $8,350 - $11,575	-2,500 Reduced 8.77%	26,000 $87,000
Q2 2021 Jul 02, 2021	BUY	$3.38 - $5.71 $96,330 - $162,735	28,500 New	28,500 $109,000
Q1 2021 Apr 01, 2021	SELL	$3.77 - $6.05 $196,040 - $314,600	-52,000 Closed	0 $0
Q4 2020 Jan 04, 2021	BUY	$3.12 - $4.08 $43,680 - $57,120	14,000 Added 36.84%	52,000 $192,000
Q3 2020 Oct 01, 2020	BUY	$3.09 - $4.14 $47,895 - $64,169	15,500 Added 68.89%	38,000 $143,000
Q2 2020 Jul 01, 2020	BUY	$1.47 - $2.97 $33,075 - $66,825	22,500 New	22,500 $67,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $683M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

Stay updated on Thomasville National Bank with notifications on news.